Stockscreener 앱 받기
18.53
5.83%
1.02
시간 외 거래:
18.52
-0.01
-0.05%
전일 마감가:
$17.51
열려 있는:
$17.46
하루 거래량:
1.43M
Relative Volume:
0.98
시가총액:
$1.70B
수익:
$12.59M
순이익/손실:
$-212.39M
주가수익비율:
-6.0059
EPS:
-3.0853
순현금흐름:
$-185.92M
1주 성능:
+8.11%
1개월 성능:
+10.69%
6개월 성능:
+133.96%
1년 성능:
+96.71%
1일 변동 폭
$17.30
$19.01
1주일 범위
$17.30
$19.01
52주 변동 폭
$5.1501
$19.01
이뮤놈 Stock (IMNM) Company Profile
명칭
Immunome Inc
전화
610-321-3700
주소
18702 N. CREEK PARKWAY, BOTHELL
IMNM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
18.53 | 1.61B | 12.59M | -212.39M | -185.92M | -3.0853 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
이뮤놈 Stock (IMNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-22 | 개시 | Goldman | Buy |
| 2025-09-05 | 개시 | Craig Hallum | Buy |
| 2025-04-02 | 개시 | Lake Street | Buy |
| 2024-11-08 | 개시 | Stephens | Overweight |
| 2024-05-31 | 개시 | Piper Sandler | Overweight |
| 2024-04-30 | 개시 | JP Morgan | Overweight |
| 2024-04-15 | 개시 | Guggenheim | Buy |
| 2024-01-29 | 개시 | Leerink Partners | Outperform |
| 2023-12-19 | 개시 | Wedbush | Outperform |
| 2021-10-29 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
이뮤놈 주식(IMNM)의 최신 뉴스
Immunome stock hits 52-week high at $18.79 By Investing.com - Investing.com Nigeria
Will Immunome Inc. stock attract more institutional investorsEarnings Overview Summary & Fast Momentum Stock Entry Tips - newser.com
What technical signals suggest for Immunome Inc. stockEarnings Overview Summary & AI Driven Stock Movement Reports - newser.com
How Immunome Inc. stock benefits from tech adoptionTrade Analysis Summary & Short-Term Trading Alerts - newser.com
Will Immunome Inc. stock outperform value stocks2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com
Is Immunome Inc. stock a safe haven assetGDP Growth & Weekly Top Gainers Trade List - newser.com
Is Immunome Inc. stock bottoming out2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com
Can swing trading help recover from Immunome Inc. lossesJuly 2025 Action & Daily Volume Surge Signals - newser.com
Discipline and Rules-Based Execution in IMNM Response - news.stocktradersdaily.com
Stephens raises Immunome stock price target to $33 on varegacestat potential - Investing.com Nigeria
IMNM Analyst Rating Update: Stephens & Co. Raises Price Target | - GuruFocus
Immunome price target raised to $33 from $25 at Stephens - TipRanks
Is Immunome’s (IMNM) Improved Efficiency a Sign of Lasting Strength in the Biotech Race? - simplywall.st
Can Immunome Inc. stock deliver surprise earnings beat2025 Buyback Activity & Expert Curated Trade Setup Alerts - newser.com
Historical volatility pattern of Immunome Inc. visualizedQuarterly Risk Review & Weekly Top Gainers Trade List - newser.com
What drives Immunome Inc stock priceSmall Cap Stock Opportunities & Free Daily Market Summary and Trend Reports - earlytimes.in
What Makes Escorts Kubota Limited a Resilient Investment During CrisesCash Flow Trends & Master Timing Market Moves - earlytimes.in
Immunome stock hits 52-week high at 17.89 USD By Investing.com - Investing.com Canada
How Immunome Inc. stock performs in rate cut cyclesMarket Weekly Review & AI Powered Market Entry Ideas - newser.com
Immunome stock hits 52-week high at 17.89 USD - Investing.com
Will Immunome Inc. stock reach Wall Street targetsQuarterly Investment Review & High Conviction Investment Ideas - newser.com
Immunome, Inc. Reports Q3 2025 Financial Results - TipRanks
Can Immunome's (IMNM) Reduced Losses Point to a Sustainable Shift in Operational Strategy? - simplywall.st
이뮤놈 (IMNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
이뮤놈 주식 (IMNM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BIENAIME JEAN JACQUES | Director |
Jun 03 '25 |
Buy |
9.38 |
5,000 |
46,900 |
36,415 |
| Higgins Jack | Chief Scientific Officer |
Mar 27 '25 |
Option Exercise |
1.35 |
5,200 |
7,020 |
18,729 |
| BIENAIME JEAN JACQUES | Director |
Mar 25 '25 |
Buy |
7.78 |
7,800 |
60,684 |
31,415 |
| SIEGALL CLAY B | President and CEO |
Mar 26 '25 |
Buy |
7.29 |
137,100 |
999,459 |
806,736 |
| BIENAIME JEAN JACQUES | Director |
Mar 24 '25 |
Buy |
8.21 |
7,000 |
57,470 |
23,615 |
| Tsai Philip | Chief Technology Officer |
Mar 24 '25 |
Buy |
8.42 |
12,300 |
103,566 |
33,300 |
| SIEGALL CLAY B | President and CEO |
Jan 31 '25 |
Buy |
7.75 |
150,000 |
1,162,500 |
669,636 |
| SIEGALL CLAY B | President and CEO |
Nov 22 '24 |
Buy |
9.78 |
33,943 |
331,918 |
519,636 |
1.38%
1.42%
자본화:
|
볼륨(24시간):